Reach Us +1 218 451 2974
Editor - Patrick Genyan Yang | Centers for Disease Control and P | 26193
ISSN: 2576-1420

Journal of Infectious Diseases and Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Patrick Genyan Yang

Patrick Genyan Yang
Patrick Genyan Yang
Centers for Disease Control and Prevention


Dr. Yang had medical training in Laboratory Medicine and Clinical pathology in 1993. While working in a hospital after graduation, Dr. Yang was interested in how molecules were related to disease onset, progress and recovery, and how to detect them in a rapid, sensitive and specific manner. This interest brought him to purse a PhD degree in Molecular Biology and Biochemistry in 1995. Regulation of gene transcription plays roles in homeostasis, reproduction, and cancer development. In his PhD studies and postdoctoral training, Dr. Yang explored transcriptional regulation of genes involved in spermatogenesis, onset and progression of prostate cancer and leukemia. After two years as a research faculty in Vanderbilt University, Dr. Yang realized work in public health has more profound and broad impact than on a particular disease. Therefore, he moved to CDC where he currently work as a laboratory scientist in infectious diseases, mainly focusing on influenza virus infections.

Research Interest

Non-malignant blood disorders and birth defects; malignant blood disorders, including acute myeloid leukemia (AML);